Venker Eric
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1801917. Latest Form 4 filed Oct 22, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Roivant Sciences Ltd.ROIV | President & Immunovant CEO, Officer | 2 | 2026-10-20 | 2026-10-20 |
Transactions: 2
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-20 | Roivant Sciences Ltd.President & Immunovant CEO, Officer | Sale | 14,144 | $35.42 | $501.0k | Form 4 |
| 2026-10-20 | Roivant Sciences Ltd.President & Immunovant CEO, Officer | Sale | 185,856 | $35.09 | $6.5m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 2, 2026, 23:07 ET. Listed shows no prices and gives no investment advice.